A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Treatment With Sirukumab (CNTO 136) in Patients With Active Lupus Nephritis
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2018 ◽
Vol 33
(suppl_1)
◽
pp. i636-i637
Keyword(s):
Keyword(s):
2018 ◽
Keyword(s):
Keyword(s):
Keyword(s):